Longevity News and Headlines

Novo Nordisk CEO Looks Beyond Weight Loss to Longevity and Aesthetics
NewsJun 7, 2026

Novo Nordisk CEO Looks Beyond Weight Loss to Longevity and Aesthetics

Novo Nordisk CEO Mike Doustdar said the company’s blockbuster GLP‑1 drugs, Ozempic and Wegovy, could be leveraged for longevity research and aesthetic medicine, not just weight loss. Recent data suggest semaglutide may protect heart, liver and kidney function independent of...

By Fortune – All Content
The Personality Trait Linked To Positive Aging
NewsJun 7, 2026

The Personality Trait Linked To Positive Aging

A new study published in The International Journal of Aging and Human Development finds that optimism is linked to living nearly eight years longer on average. Researchers surveyed 244 adults, asking them to list hoped‑for and feared future selves, and...

By PsyBlog
How To Take Early Action Against Cognitive Decline, From A Neurologist
NewsJun 7, 2026

How To Take Early Action Against Cognitive Decline, From A Neurologist

Preventive neurologist Richard Isaacson stresses that early detection of cognitive decline can uncover reversible causes, which account for about 5% of cases. He advocates a basic clinical screen followed by comprehensive blood biomarker panels—including tau, amyloid, GFAP, NFL, APOE4 and...

By Mindbodygreen
A Northwestern Study Just Revealed a Major Breakthrough in the Fight Against Cognitive Decline
NewsJun 6, 2026

A Northwestern Study Just Revealed a Major Breakthrough in the Fight Against Cognitive Decline

Northwestern University researchers found that a class of flu antivirals can slow brain aging and reduce cognitive decline in people living with chronic viral infections, notably HIV. The study, published in Med, identified degrading glycans as a biological driver of...

By Inc. — Leadership
"Zombie" Cells Are A Sign Of Aging — What Health Risks Do They Pose?
NewsJun 6, 2026

"Zombie" Cells Are A Sign Of Aging — What Health Risks Do They Pose?

A recent precision‑aging review in the journal Aging challenges the blanket view that all senescent, or “zombie,” cells are detrimental. It shows that while some senescent cells fuel inflammation and disease, others, such as pancreatic beta cells, can enhance physiological...

By Mindbodygreen
Three Decades of Progress Since the Discovery of Senescence-Associated Beta-Galactosidase
NewsJun 6, 2026

Three Decades of Progress Since the Discovery of Senescence-Associated Beta-Galactosidase

The 1995 discovery of senescence‑associated beta‑galactosidase (SA‑β‑gal) gave researchers the first reliable tool to spot senescent cells, sparking three decades of rapid progress in aging biology. Subsequent work has defined a suite of hallmarks—including lysosomal expansion, SASP secretion, mitochondrial decline,...

By News-Medical.Net
Targeting US$610 Billion Longevity Market, Biotech Firms Race to Reverse Ageing
NewsJun 6, 2026

Targeting US$610 Billion Longevity Market, Biotech Firms Race to Reverse Ageing

Biotech firms are racing to tap the estimated $610 billion longevity market by developing therapies that reverse or slow ageing. Companies such as Beijing‑based METiS TechBio and California‑based Human Longevity are deploying artificial‑intelligence platforms to map genetic errors and predict age‑related...

By South China Morning Post – Asia
Sarcopenia and Satellite Cell Homeostasis Disruption: The Dual Function of NAD+ Metabolism
NewsJun 5, 2026

Sarcopenia and Satellite Cell Homeostasis Disruption: The Dual Function of NAD+ Metabolism

A new review in Frontiers in Nutrition examines how NAD⁺ metabolism exerts a dual, dose‑dependent influence on muscle satellite cell (MuSC) homeostasis, a key driver of sarcopenia. Moderate supplementation with precursors such as NMN or NR activates SIRT1 and SIRT3,...

By Frontiers in Nutrition
How This Little-Known Compound Impacts Fat, Brain & Muscle Health
NewsJun 5, 2026

How This Little-Known Compound Impacts Fat, Brain & Muscle Health

A recent Cell Metabolism study identified S‑1‑propenyl‑L‑cysteine (S1PC), a compound in aged garlic extract, as a trigger for a fat‑to‑brain signaling cascade that raises eNAMPT and supports muscle function in aged mice. The pathway bypasses direct muscle action, instead sending...

By Mindbodygreen
‘Unmatched’: Nutra Healthspan Summit Returns for November 2026
NewsJun 5, 2026

‘Unmatched’: Nutra Healthspan Summit Returns for November 2026

The Nutra Healthspan Summit returns for its second edition on November 10‑11, 2026, at Convene in London. The two‑day forum will convene brands, researchers, product developers, and investors to explore cutting‑edge advances in cellular aging, mitochondrial function, women’s health, cognition,...

By NutraIngredients (EU)
Forever Healthy Foundation Launches Evipedia.ai
NewsJun 3, 2026

Forever Healthy Foundation Launches Evipedia.ai

The Forever Healthy Foundation launched evipedia.ai, an open online encyclopedia offering more than 500 evidence‑based reviews of health and longevity interventions, from first‑generation rejuvenation therapies to supplements and lifestyle protocols. Each entry provides a one‑page Quick Reference Sheet and a...

By Lifespan.io
The Best Foods for Brain Health May Change as You Age
NewsJun 3, 2026

The Best Foods for Brain Health May Change as You Age

A new narrative review in Nutrients surveyed 54 studies to map how specific animal‑ and plant‑based foods influence brain development and cognitive aging. The authors found that eggs, dairy, meat, and seafood, as well as berries, whole grains, leafy greens,...

By News-Medical.Net
STAT+: Longevity Startup NewLimit Raises $435 Million Ahead of First Clinical Trial
NewsJun 2, 2026

STAT+: Longevity Startup NewLimit Raises $435 Million Ahead of First Clinical Trial

Longevity biotech NewLimit announced a $435 million Series C round, pushing its valuation to roughly $3.1 billion. The funding, led by Founders Fund and joined by Thrive Capital and Lilly Ventures, backs the company’s first clinical trial of a liver‑targeted therapy slated for...

By STAT (Biotech)
The Thalion Initiative: A New Non-Profit With Big Ambitions
NewsJun 2, 2026

The Thalion Initiative: A New Non-Profit With Big Ambitions

The Thalion Initiative, a newly launched non‑profit, aims to accelerate fundamental aging biology with a 15‑year, $710 million roadmap. Its first phase focuses on building a $100‑120 million, 200‑species, multi‑omics mammalian biobank and developing high‑resolution microscopy and mass‑spec tooling. Backed by a...

By Lifespan.io